# Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

> **NCT01062971** · PHASE2 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 124 (actual)

## Conditions studied

- Primary Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** dorzolamide-timolol-brimonidine

## Key facts

- **NCT ID:** NCT01062971
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-08
- **Final completion:** 2008-06
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01062971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01062971, "Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01062971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*